Product Information

ERYTHROMYCIN 400 MG/5 ML SUSP is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.6691 per ML under NDC 60219150402. Its NADAC has been published 128 times since Jun 5, 2024.

FDA first approved this application on Nov 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERYTHROMYCIN 400 MG/5 ML SUSP

Erythromycin
$1.6691per ML

Strength

400 mg/5mL

NDC

60219150402

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ERYTHROMYCIN ETHYLSUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211204

FDA Approved

11/1/2019

TE Code

AB

On Market Since

12/2/2023

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has been published 128 times since Jun 5, 2024, and over the history we have for it it has declined 22.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6691 per ML
All-time high$2.2830 (Oct 15, 2025)
All-time low$1.6691 (Oct 21, 2026)
52-week high$2.0426
52-week low$1.6691
Median price$1.9095
Average price$1.9291
Largest weekly change-15.4% (Jul 17, 2024)
Weeks tracked128
Tracking sinceJun 5, 2024

Price History

1W

0.0%

1M

-4.3%

3M

-4.5%

6M

-9.2%

1Y

-22.2%

3Y

N/A

5Y

N/A

All

-22.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN 400 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 400 MG/5 ML SUSP, manufactured by Amneal Pharmaceuticals NY LLC, is $1.6691 per ML (NDC 60219150402), effective Nov 11, 2026.

How has the price of ERYTHROMYCIN 400 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has declined 22.6%. It has been tracked across 128 weekly CMS publications since Jun 5, 2024.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 400 MG/5 ML SUSP?

Since Jun 5, 2024, the NADAC for ERYTHROMYCIN 400 MG/5 ML SUSP has ranged from a low of $1.6691 (Oct 21, 2026) to a high of $2.2830 (Oct 15, 2025), with a median of $1.9095 per ML.

Are there cheaper alternatives to ERYTHROMYCIN 400 MG/5 ML SUSP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN 400 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures ERYTHROMYCIN 400 MG/5 ML SUSP?

ERYTHROMYCIN 400 MG/5 ML SUSP (NDC 60219150402) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.